Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 457, pseudogene (RN7SL457P) is a processed pseudogene in humans, not a protein-coding gene or valid drug target[8][6][7]. It belongs to the family of 7SL RNA pseudogenes, which are numerous (~hundreds) in the human genome and are derived from the gene encoding the 7SL RNA component of the signal recognition particle (SRP)[1][5][3]. Pseudogenes like RN7SL457P are typically transcriptionally silent or, if transcribed, do not produce functional molecules and do not play a direct role in biological pathways, signaling, or disease; they serve as remnants from evolutionary genetic events such as reverse transcription and genomic insertion of RNA molecules[1][5]. There is no evidence that RN7SL457P is expressed or acts as a therapeutic target, nor is it associated with drug interactions, mechanisms of drug action, safety concerns, or biomarker applications based on available knowledge and search results[6][8][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 457, pseudogene (RN7SL457P).